Raco Ivan Jordanov
Vorstandsvorsitzender bei JHL BIOTECH, INC.
Profil
Raco Ivan Jordanov is the founder of Eden Biologics, Inc., a company founded in 2012, where he currently holds the title of Co-Chairman & Chief Executive Officer.
He also held the position of Senior Director-Singapore Operations at Genentech, Inc. In addition, he served as an Independent Non-Executive Director at Austar Lifesciences Ltd.
from 2014 to 2017.
Mr. Jordanov obtained an MBA from National University in 1980 and an undergraduate degree from the University of California in 1975.
Aktive Positionen von Raco Ivan Jordanov
Unternehmen | Position | Beginn |
---|---|---|
JHL BIOTECH, INC. | Vorstandsvorsitzender | 12.06.2012 |
Ehemalige bekannte Positionen von Raco Ivan Jordanov
Unternehmen | Position | Ende |
---|---|---|
AUSTAR LIFESCIENCES LIMITED | Direktor/Vorstandsmitglied | 21.10.2017 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
Ausbildung von Raco Ivan Jordanov
University of California | Undergraduate Degree |
National University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
AUSTAR LIFESCIENCES LIMITED | Producer Manufacturing |
Private Unternehmen | 2 |
---|---|
Eden Biologics, Inc.
Eden Biologics, Inc. Pharmaceuticals: MajorHealth Technology Eden Biologics, Inc. is engaged in the manufacture and sale of bio-pharmaceuticals products. It offers cell line cloning, antibody cloning, monoclonal antibody, cell line development, master and working cell banks, cell culture process development, purification process development, formulation development, and analytical assays. The company was founded on June 14, 2012 and is headquartered in Zhupei, Taiwan. | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |